GUIDELINES FOR USAGE OF DIAGNOSTIC PROCEDURES PRIOR TO INITIATION OF ANTINEOPLASTIC TREATMENT – CROATIAN SOCIETY FOR MEDICAL ONCOLOGY CLINICAL RECOMMENDATIONS Part I. tumors of urogenital system (renal cell cancer, urinary bladder cancer, prostatic cancer, testicular cancer), tumors of gastrointestinal system (oesophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer, biliary ducts cancer, hepatocellular cancer, neuroendocrine neoplasms)
Robert Šeparović, Ljubica Vazdar, Ana Tečić Vuger, Mirjana Pavlović, Milena Gnjidić, Juraj Prejac, Irma Goršić, Dragan Trivanović, Mislav Čonkaš, Željko Vojnović, Gordana Horvatić-Herceg, Ana Marija Alduk, Natalija Dedić Plavetić, Damir Vrbanec
Cancer is the second most important cause of death in our country, immediately after cardiovascular diseases. With the assumption that cancer incidence and mortality will increase in the next years, projections show that the costs of diagnosis and treatment of cancer will be significantly increased, both due to the introduction of new diagnostic techniques and innovative medicines and treatment methods. Consequently, the imperative of making optimal use of financial resources, available personnel and techniques is all the more necessary in order to ensure the continuity of adequate diagnosis and treatment. Optimal use of diagnostic methods can prevent unnecessary processing delay, waste of financial resources and unnecessary burden on healthcare workers, and shorten waiting lists. HDIO has made these guidelines with the aim of overcoming these problems, rationalizing and standardizing diagnostic procedures in everyday clinical practice. Guidelines should help us to select, from the entire range of diagnostic procedures available, those which are most relevant to a particular localization and clinical extension of the disease.